Find key information for shareholders in 4D pharma plc
4D pharma plc
9 Bond Court
Leeds LS1 2JZ
For all enquiries please contact email@example.com
This information was last updated as of 30 June 2021.
There are 180,300,967 ordinary shares in issue. There are no ordinary shares held in treasury. Therefore, the total number of voting rights in the Company is 180,300,967.
The table below shows the interests of major shareholders of 3% or more which have been notified to the Company or of which the Company is aware.
Insofar as the Company is aware, the percentage of the Company’s issued ordinary shares that is not in public hands is 10%. 1
There are no restrictions as to the transfer of ordinary shares.
Major shareholders (Ordinary shares)
Ordinary shares held
|Hargreaves Lansdown Asset Management||21,235,818||11.78%|
|4D pharma plc Directors and related holdings||18,025,411||10.00%|
|South Ocean Capital Management LLC and connected parties||15,619,290||8.66%|
|Interactive Investor Trading||11,097,500||6.16%|
|Merck Sharp & Dohme Corp||8,315,023||4.61%|
|Halifax Share Dealing||6,389,844||3.54%|
American Depositary Shares (ADSs)
|American Depositary Shares (ADSs) via JPMorgan Chase Bank N.A.||28,703,888||15.92%|
1 Shares not in public hands are defined as those held by 4D pharma plc Directors and related holdings and substantial shareholders of ≥10%
Meetings and voting
Advisers and registrars
1 Bartholemew Lane
London, EC2N 2AX
Bryan Garnier & Co. Limited
15 St. Botolph Street
London, EC3A 7BB
RSM UK Audit LLP
3 Hardman Street
Manchester, M3 3HF
10th Floor, Central Square, 29 Wellington Street
Leeds, LS1 4DL